Support affordability with ease and peace of mind
PharmacyElite™ supports our biopharma partners with safe, fast and compliant non-commercial dispensing for your patient assistance program (PAP) or other initiatives.
Flexible non-commercial dispensing support for PAP and related programs
Our non-commercial dispensing services ensure that free and reduced-price drugs are separately inventoried, tagged and dispensed as dedicated consigned inventory. By keeping these drugs readily available, yet separately tracked from pharmacy supplies, PharmacyElite™ can help biopharma manufacturers:
- Expedite a patient’s time to therapy
- Reserve a percentage of limited-distribution or exclusive drugs for patients in need
- Support adherence through availability and affordability
Optimized processes for non-commercial dispensing
Whether you’re making plans for PAP dispensing, exploring quick start programming or preparing to offer bridge services, PharmacyElite streamlines the process for you and the patient populations you serve. From hub qualification to dispensing, our high-touch process not only revolves around efficiency, but also around transparency, accuracy and compliance.
Once a patient has been approved for affordability support, the prescription is sent directly to our knowledgeable triage team, and we maintain a highly efficient operational flow from hub qualification to dispense. During the product intake process, therapy-specific data is entered into a centralized platform to capture important details and make them securely available to authorized stakeholders.
Real-time inventory visibility
PharmacyElite’s efficient, compliance-driven non-commercial dispensing services enable manufacturers to precisely track, reconcile and report consigned inventory — from hub qualification to dispense.
Questions about hub program design or support models?
Designed for complex patient journeys
Purpose-built hub programs supporting oncology, rare disease and cell & gene therapy.
Navigating coverage considerations
Support for coverage and reimbursement considerations associated with non-commercial therapies.
Enabling connected workflows
Technology-enabled support to integrate hub services with biopharma systems.